Medistem completes first phase of diabetes technology project
The project was based on using ERC technology licensed from Yale University to treat type 1diabetes. Shumakov Center Biomedical Research and Technology Institute head and professor Viktor Sevastianov
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.